Demonstration venue · read-only. Every page can be browsed; the buttons that would change it are switched off. Create an account to run TaxoReview on your own data. A simulation from public publication records: the people listed were not invited and did not agree to review.
? Tutorial for this page
Demo Data from EDBT 2026 / reviewers in the wild / expert

Tinu Thomas

dblp:183/6899 · DBLP profile ↗
← Back
2ranked-venue papers
0as first author
1since 2021 · last 2024
—ORCID · unresolved

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 2 · 1 since 2021

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
1 paper
Bioinformatics and computational biology · 100%

Topics — the 1 heaviest of 2, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology › systems bioinformatics
pathway analysis		 0.812024
Probabilistic pathway-based multimodal factor analysis · Bioinform. 2024

Methods — techniques the papers use, named apart from their topics

probabilistic factor analysis · 0.8
YearPublicationVenuePosition
2024 Probabilistic pathway-based multimodal factor analysis
Alexander Immer, Stefan Stark, Francis Jacob, Ximena Bonilla, Tinu Thomas, André Kahles, Sandra Götze, Emanuela S. Milani, Bernd Wollscheid, Gunnar Rätsch, Kjong-Van Lehmann
 Bioinform.5
2016 Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genes
abstract
The purpose of this article is to inform readers about technical challenges that we encountered when assembling exome sequencing data from the 'Simplifying Complex Exomes' (SIMPLEXO) consortium-whose mandate is the discovery of novel genes predisposing to breast and ovarian cancers. Our motivation is to share these obstacles-and our solutions to them-as a means of communicating important technical details that should be discussed early in projects involving massively parallel sequencing.
Steven N. Hart, Kara N. Maxwell, Tinu Thomas, Vignesh Ravichandran, Bradley Wubberhorst, Robert J. Klein, Kasmintan Schrader, Csilla Szabo, Jeffrey N. Weitzel, Susan L. Neuhausen, Katherine Nathanson, Kenneth Offit, Fergus J. Couch, Joseph Vijai
 Briefings Bioinform.3